IAN T. BOTHWELL - 14 Jun 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
14 Jun 2021
Net transactions value
-$28,890
Form type
4
Filing time
16 Jun 2021, 21:47:20 UTC
Previous filing
11 Jun 2021
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $7,000 -50,000 -0.03% $0.1400 148,208,726 14 Jun 2021 Direct
transaction OCEL Common Stock Sale $8,000 -50,000 -0.03% $0.1600 148,158,726 15 Jun 2021 Direct
transaction OCEL Common Stock Sale $8,050 -50,000 -0.03% $0.1610 148,108,726 16 Jun 2021 Direct
transaction OCEL Common Stock Sale $5,840 -40,000 -0.03% $0.1460 148,068,726 16 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.